These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

645 related items for PubMed ID: 17875707

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.
    Cancer Res; 2006 May 01; 66(9):4672-80. PubMed ID: 16651418
    [Abstract] [Full Text] [Related]

  • 3. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
    Jacquemart IC, Springs AE, Chen WY.
    Int J Oncol; 2009 Feb 01; 34(2):517-28. PubMed ID: 19148488
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Preferential killing of breast tumor initiating cells by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine/tesmilifene.
    Deng T, Liu JC, Pritchard KI, Eisen A, Zacksenhaus E.
    Clin Cancer Res; 2009 Jan 01; 15(1):119-30. PubMed ID: 19118039
    [Abstract] [Full Text] [Related]

  • 6. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.
    Vaillant F, Asselin-Labat ML, Shackleton M, Forrest NC, Lindeman GJ, Visvader JE.
    Cancer Res; 2008 Oct 01; 68(19):7711-7. PubMed ID: 18829523
    [Abstract] [Full Text] [Related]

  • 7. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
    Zhou H, Chen WD, Qin X, Lee K, Liu L, Markowitz SD, Gerson SL.
    Oncogene; 2001 Sep 20; 20(42):6009-17. PubMed ID: 11593408
    [Abstract] [Full Text] [Related]

  • 8. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
    Rudolph-Owen LA, Chan R, Muller WJ, Matrisian LM.
    Cancer Res; 1998 Dec 01; 58(23):5500-6. PubMed ID: 9850086
    [Abstract] [Full Text] [Related]

  • 9. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors.
    Cho RW, Wang X, Diehn M, Shedden K, Chen GY, Sherlock G, Gurney A, Lewicki J, Clarke MF.
    Stem Cells; 2008 Feb 01; 26(2):364-71. PubMed ID: 17975224
    [Abstract] [Full Text] [Related]

  • 10. Use of mouse mammary tumour virus (MMTV)/neu transgenic mice to identify genes collaborating with the c-erbB-2 oncogene in mammary tumour development.
    Jolicoeur P, Bouchard L, Guimond A, Ste-Marie M, Hanna Z, Dievart A.
    Biochem Soc Symp; 1998 Feb 01; 63():159-65. PubMed ID: 9513720
    [Abstract] [Full Text] [Related]

  • 11. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
    Blavier L, Lazaryev A, Dorey F, Shackleford GM, DeClerck YA.
    Cancer Res; 2006 Mar 01; 66(5):2691-9. PubMed ID: 16510589
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu.
    Hewitt SC, Bocchinfuso WP, Zhai J, Harrell C, Koonce L, Clark J, Myers P, Korach KS.
    Cancer Res; 2002 May 15; 62(10):2798-805. PubMed ID: 12019156
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Challenge with mammary tumor cells expressing MHC class II and CD80 prevents the development of spontaneously arising tumors in MMTV-neu transgenic mice.
    Jabrane-Ferrat N, Campbell MJ, Esserman LJ, Peterlin BM.
    Cancer Gene Ther; 2006 Nov 15; 13(11):1002-10. PubMed ID: 16841083
    [Abstract] [Full Text] [Related]

  • 17. Alcohol promotes mammary tumor development via the estrogen pathway in estrogen receptor alpha-negative HER2/neu mice.
    Wong AW, Dunlap SM, Holcomb VB, Nunez NP.
    Alcohol Clin Exp Res; 2012 Apr 15; 36(4):577-87. PubMed ID: 21981381
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.
    Lo PK, Kanojia D, Liu X, Singh UP, Berger FG, Wang Q, Chen H.
    Oncogene; 2012 May 24; 31(21):2614-26. PubMed ID: 21996747
    [Abstract] [Full Text] [Related]

  • 20. Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer.
    Kondratyev M, Kreso A, Hallett RM, Girgis-Gabardo A, Barcelon ME, Ilieva D, Ware C, Majumder PK, Hassell JA.
    Oncogene; 2012 Jan 05; 31(1):93-103. PubMed ID: 21666715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.